Biotech Archives - Page 11 of 795

2 minute read

Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal

June 5, 3:26 PM

Amgen announced Phase 3 trial results for Uplizna for IgG4-related disease, achieving an 87% reduction in flare risk. All key secondary endpoints were met with no new safety signals.

AMGN

2 minute read

Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment

By Aaron Bry

June 5, 3:26 PM

FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision.

ATAI

2 minute read

Medtronic Recalls Some Versions Of Software Used For Cranial Surgery

By Vandana Singh

June 5, 3:23 PM

Medtronic is recalling specific StealthStation S8 application versions due to a serious software error affecting surgical navigation displays. Medtronic is providing a free software update to fix the problem.

MDT

2 minute read

What’s Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?

By Vandana Singh

June 5, 3:17 PM

Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment. Further trials needed to confirm efficacy and safety.

AKRO

1 minute read

Novo Integrated Sciences Wholly Owned Canadian Subsidiary, Acenzia, Selected To Participate In Protein Industries Canada Program To Develop Plant Based Protein Products; Project Investment Amounts Expected To Total $5.4M With Acenzia Investing $600K, P…

By Benzinga Newsdesk

June 5, 3:01 PM

Project investment amounts expected to total $5.4 million with Acenzia investing $600 thousand, Protein Industries Canada investing $2.3 million, and two other partner companies investing $2.5 millionNovo Integrated

NVOS

1 minute read

Why Is Infectious Disease-Focused Vir Biotechnology Stock Trading Higher On Wednesday?

By Vandana Singh

June 5, 2:51 PM

Vir Biotechnology reports promising Phase 2 SOLSTICE hepatitis delta trial results, showing high virologic response and ALT normalization rates with tobevibart and elebsiran.

VIR

2 minute read

British Agency Supports Eli Lilly’s Weight Loss Drug Mounjaro, Diverging From Restrictions on Rival Novo Nordisk’s Wegovy

By Vandana Singh

June 5, 12:21 PM

NICE recommends Eli Lilly's Mounjaro for obesity, omitting time limits applied to Novo Nordisk's Wegovy, opening new avenues for long-term treatment.

LLY

1 minute read

Edwards Lifesciences Presents 5-Year Follow Up Data From PARTNER Trials Showing Clinical Outcomes For Female And Small Annulus Patients With Transcatheter Aortic Valve Replacement At The New York Valves 2024: The Structural Heart Summit

By Benzinga Newsdesk

June 5, 11:48 AM

Edwards Lifesciences (NYSE:EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through

2 minute read

Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus

By Vandana Singh

June 5, 10:55 AM

Atea Pharmaceuticals announces 97% SVR12 in Phase 2 HCV study of bemnifosbuvir. Data shows high efficacy, safety, and low resistance risk.

AVIR

2 minute read

SCHOTT Pharma And KORU Medical Systems Announce Collaboration To Advance Large Volume Subcutaneous Infusion

By Benzinga Newsdesk

June 5, 9:05 AM

The companies, KORU Medical, manufacturer of the proprietary, large-volume, Freedom Infusion System (the "Freedom System") and SCHOTT Pharma, manufacturer of SCHOTT TOPPAC® prefillable polymer syringes (PFS), intend

KRMD